Clinical Trial

Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa

Study acronym: PPREPP-SA
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 5, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a funded implementation study designed to evaluate the efficacy of recruiting and retaining high-risk individuals on pre-exposure prophylaxis (PrEP) within multiple private pharmacies (and online platforms in South Africa)
Trial Details
NCT Number NCT07006246
Lead Sponsor Professor Francois Venter
Collaborators: Bill and Melinda Gates Foundation
Conditions HIV Infection
Enrollment 1,900 participants
Start Date 2023-05-19
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-05